US - CDC Alerts Healthcare Providers of Rising Dengue Cases

The CDC warns of increased dengue infections in the US. Over 9.7 million cases were reported in the Americas between January 1 and June 24, 2024, double last year's total.

Healthcare providers should promote prevention, use proper diagnostics, and report cases promptly.

WHO recently approved Takeda's dengue vaccine Qdenga for UN procurement. Qdenga is approved in several countries, alongside Sanofi's Dengvaxia.

Dengue, spread by Aedes mosquitoes, causes fever, headaches, vomiting, rashes, and severe cases can lead to hemorrhagic fever and death.